Educating the Regulators

"Regulatory Opportunities" from the NanoBusiness Alliance and Preston Gates Ellis & Rouvelas Meeds LLP: The federal government is beginning to address the regulatory issues raised by nanotechnology. The EPA is turning its attention to the potential environmental and public health effects of nanoparticles in the environment. The FDA is preparing to deal with nanoparticles in medical and cosmetic products. As these agencies begin to focus on nanotechnology, Alliance members will find it helpful to be involved from the outset-working with regulators to alert them to special issues, educating them about the field, and meeting with them early in the product development process in order to avoid costly course-shifting later. For assistance with regulatory matters, please contact Daniel Ritter at Preston Gates Ellis & Rouvelas Meeds LLP. Discuss